Call us: 1.405.235.2305
info@i2E.org
  • Events
  • News
  • Resources
  • Media
  • Love’s Cup
i2Ei2Ei2Ei2E
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
  • e3
  • Concept Fund
  • iMCI
  • Portfolio
  • ACT Tulsa
  • Contact

News

Modest Oklahoma investments lead to innovation

By sarah | News | 0 comment | 6 December, 2016 | 0

Modest Oklahoma investments lead to innovation By Scott Meacham Copyright 2016, © The Oklahoma Publishing Company Most of us have probably read to ourselves, our children or our grandchildren that all-time favorite, “The Little Engine that Could.” This simple tale has been teaching the value of optimism and hard work to millions of young (andRead more

Oklahoma City Finds a Sweet Spot on America’s ‘Silicon Prairie’

By admin | News | 0 comment | 29 November, 2016 | 0

If you are in a decision-making position in an Oklahoma company, is there any reason you wouldn’t want to consider doing business with a startup? You might think that there’s too much risk with a startup. Personally, I like optimism and passion. I favor businesses that stretch, that run lean, and that focus on cashflow. And I like to be part of helping a new business grow. I bet when you think about it, you do too.

Selexys a local success story for entrepreneurship

By admin | News | 0 comment | 29 November, 2016 | 0

If you are in a decision-making position in an Oklahoma company, is there any reason you wouldn’t want to consider doing business with a startup? You might think that there’s too much risk with a startup. Personally, I like optimism and passion. I favor businesses that stretch, that run lean, and that focus on cashflow. And I like to be part of helping a new business grow. I bet when you think about it, you do too.

OKC pharma firm acquired in deal valued up to $665 million

By admin | News | 0 comment | 22 November, 2016 | 0

A global pharmaceutical company will pay up to $665 million for an Oklahoma City research firm that recently completed a large trial of a drug that treats pain among those with sickle cell disease.

i2E portfolio company announces exit

By admin | News | 0 comment | 21 November, 2016 | 0

A global pharmaceutical company will pay up to $665 million for an Oklahoma City research firm that recently completed a large trial of a drug that treats pain among those with sickle cell disease.

An Emerging Tech Center: Oklahoma City notable home-grown startups

By zach | News | 0 comment | 29 February, 2016 | 0

An Emerging Tech Center: Oklahoma City notable home-grown startups in Innovation Magazine Copyright © 2016 | Innovation America Accele BioPharma (founded in 2011) — Biotechnology business accelerator located in the University Research Park, formed to create a capital-efficient mechanism to identify, finance and manage groundbreaking early stage life science technologies. http://accelebio.com Analytical Research Laboratories/DNA Solutions/The KupiecRead more

Homegrown biotech to flourish in OKC

By admin | News | Comments are Closed | 7 December, 2015 | 0

Oklahoma City has hit its share of biotech home runs.

Alexion, the biotech giant with a market capitalization of almost $40 billion, grew out of discoveries made at the Oklahoma Medical Research Foundation. Likewise, work at the University of Oklahoma Health Sciences Center gave birth to Novazyme Pharmaceuticals, which Genzyme purchased for more than $200 million in 2001. And Myriad Genetics acquired OMRF spin-off Crescendo Biosciences in 2014 for $270 million.

Big bucks in biotech

By admin | Entrepreneur, News, SeedStep Angels | Comments are Closed | 27 August, 2015 | 0

Foreign investment in Oklahoma should help the state’s biotech industry expand, said patent attorney Mike LaBrie.

Losing Our Edge

By admin | Entrepreneur, News, Publish in TEN, SeedStep Angels | Comments are Closed | 28 March, 2014 | 0

The loss of the state’s EDGE Fund has meant less funding opportunities for the state’s bioscience companies such as Caisson Biotech and Selexys Pharmaceuticals.

Bio Matters: Russell Rother

By admin | Entrepreneur, News, Publish in TEN, SeedStep Angels | Comments are Closed | 20 January, 2014 | 0

Dr. Russell Rother’s plan to return to Oklahoma in the 1990s to work in academia was sidetracked by his success in helping build Connecticut-based Alexion Pharmaceuticals into a $26 billion company.

Selexys to begin sickle cell drug trial

By admin | Entrepreneur, News, Publish in TEN, SeedStep Angels | Comments are Closed | 20 August, 2013 | 0

Oklahoma City-based Selexys Pharmaceuticals Corp. is enrolling patients in a Phase 2 trial of a drug designed to treat sickle cell disease.

Cytovance, Selexys announce deal

By admin | Entrepreneur, News, Publish in TEN, SeedStep Angels | Comments are Closed | 16 November, 2012 | 0

Cytovance Biologics Inc. has an agreement with Selexys Pharmaceuticals Corp. to produce the SelG1 monoclonal antibody for a clinical study.

12
i2E-300dpi-Trans-Light
  • Events
  • News
  • Resources
  • Media
  • Love’s Cup

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
PHONE 405/235-2305
Click HERE for printable map with directions.

Tulsa Office

100 S. Cincinnati Ave – 5th Floor, Suite 514
Tulsa, OK 74103
PHONE 918/582-5592
Copyright 2022 i2E, Inc. | All Rights Reserved
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
    • ACT Tulsa
  • e3
  • Concept Fund
  • Portfolio
  • iMCI
  • ACT Tulsa
  • Contact
i2E